Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Malignant Melanoma
Trial Locations (2)

1090

RECRUITING

UZ Brussel, Jette

RECRUITING

UZ Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER